|Articles|December 1, 2000

New Approaches for the Diagnosis and Management of Alzheimer's Disease
Volume 6
Issue 22 Suppl

Alzheimer's Disease: Clinical Treatment Options

Author(s)William E. Reichman, MD

Download PDF: Alzheimer's Disease: Clinical Treatment Options

Articles in this issue

over 25 years ago

Article

Participating Faculty

over 25 years ago

Article

Introduction

over 25 years ago

Article

Screening and Early Diagnosis of Dementia

over 25 years ago

Article

The Pharmacoeconomics of Alzheimer's Disease

over 25 years ago

Article

Managed Care Decisions in Alzheimer's Disease

over 25 years ago

Article

Conflicting Priorities in Alzheimer's Care, Primary Care, and Managed Care: Who Pays the Price?

over 25 years ago

Article

Continuing Medical Education Quiz

over 25 years ago

Article

Selected Abstracts

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Alzheimer's Disease: Clinical Treatment Options

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants

Dermatology Practices Absorb Rising Prior Authorization Costs

Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types